For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250321:nRSU6801Ba&default-theme=true
RNS Number : 6801B Optima Health PLC 21 March 2025
21 March 2025
Optima Health plc
("Optima Health" or the "Company")
Director / PDMR Shareholding
Optima Health plc (AIM: OPT), the UK's leading provider of technology enabled
corporate health and wellbeing solutions, announces that it was notified on 20
March 2025, that Jonathan Thomas, (Chief Executive Officer of the Company)
purchased 1,250 ordinary shares of £0.01 in the Company ("Ordinary Shares")
at a price of 197.69 pence per share.
In addition, Jonathan Thomas purchased a further 8 shares at 197.5p per share
on 20 March 2025. This follows the discovery of an administrative error that
resulted in the sale by Jonathan Thomas of 8 shares on 11 March 2025 at 182p
per share.
Following these transactions, Jonathan Thomas holds an interest in the Company
of 218,356 Ordinary Shares, representing approximately 0.25% of the current
issued share capital.
Contacts:
Optima Health
Jonathan Thomas, CEO +44(0)3300085113
Heidi Giles, CFO media@OptimaHealth.co.uk
Nominated Adviser and Corporate Broker
Panmure Liberum Limited +44 (0)20 3100 2000
Emma Earl / Will Goode/ Mark Rogers / Rupert Dearden
UK Financial PR Adviser optimahealth@icrinc.com
ICR Consilium
Mary-Jane Elliott / Angela Gray / Chris Welsh
About Optima Health
Optima Health is the UK's leading provider of occupational health and
wellbeing services, directly influencing and improving people's lives for 25
years. Optima Health's incredible team of professionals quickly and
effectively encapsulate client's needs, supporting organisations of all shapes
and sizes. Through tailored solutions and innovative systems, Optima Health
offers unparalleled clinical expertise to its clients. These solutions ensure
that processes are simple and allow its clients to spend more time focusing on
their employees driving a healthy, high-performing workplace. For more
information visit www.optima health.co.uk
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Jonathan Thomas
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Optima Health plc
b) LEI 213800TOPWJSRCW4ON08
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BRSCY602
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s)
Purchase Price Volume
197.69 pence 1,250 shares
d) Aggregated information
- Aggregated volume n/a
- Price
e) Date of the transaction 20 March 2025
f) Place of the transaction London Stock Exchange, AIM Market (XLON)
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Jonathan Thomas
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Optima Health plc
b) LEI 213800TOPWJSRCW4ON08
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of £0.01 each
Identification code GB00BRSCY602
b) Nature of the transaction Sale and purchase of shares
c) Price(s) and volume(s)
Sale Price Volume
182 pence 8 shares
Purchase Price Volume
197.5 pence 8 shares
d) Aggregated information
- Aggregated volume n/a
- Price
e) Date of the transaction Sale of shares - 11 March 2025
Purchase of shares - 20 March 2025
f) Place of the transaction London Stock Exchange, AIM Market (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHKFLBLEXLLBBQ